Q Fever Vaccine Stock Set to Run Out

Constrained supply of the Q fever vaccine in Australia is expected to continue into late December 2026 following manufacturing delays.

Updated on Nov. 11, 2026 in Diseases

Bold vector editorial illustration of unlabeled glass vials in a cardboard crate with one empty slot, conveying a stalled vaccine supply.
Constrained Q fever vaccine supply in Australia is expected to last until late December 2026 after manufacturer CSL Seqirus reported production delays. AI Illustration. Upload story photo >

Live Poll

Do you think Australia's vaccine supply is reliable enough for rural communities?

The Q fever vaccine is expected to run out in Australia this November, with supply from manufacturer CSL Seqirus expected to resume in late December 2026. Australia recorded 991 Q fever cases last year, the highest since national monitoring began in 1991.

Why it matters

Each vaccine batch takes nine months to produce, and raw material supply issues and manufacturing equipment failures have prevented about three or four batches from reaching the market. Australians working with livestock, including dairy staff, may be unable to be vaccinated during the shortage.

Australia recorded 991 Q fever cases last year, the highest since national monitoring began in 1991, while each vaccine batch takes nine months to produce. Whether the two expedited batches expected in late December will fully meet demand has not been confirmed.

The players

CSL Seqirus

CSL Seqirus is the influenza and vaccine business of Australian biotechnology company CSL, contracted by the Australian Department of Health to manufacture and supply the Q fever vaccine.

The details

Q fever is spread by animals, including sheep and cattle, and causes severe flu-like symptoms that can become chronic and lead to serious cardiovascular complications in some cases. CSL Seqirus, contracted by the Australian Department of Health to supply the vaccine, has cited raw material supply issues and unexpected manufacturing equipment problems on filling lines, and is moving operations to two new sites in Melbourne. Rawsonville dairy owner Erika Chesworth has been unable to vaccinate her staff since March.

Timeline

  1. March 2026: Rawsonville dairy owner Erika Chesworth first unable to vaccinate her staff.

  2. 2025: Australia recorded 991 Q fever cases, the highest since national monitoring began in 1991.

  3. 11 November 2026: Vaccine stock expected to run out this week.

  4. Late December 2026: Two expedited vaccine batches expected to become available.

Big Picture

The stock-out tests the reliability of the Department of Health's 10-year, $1 billion supply agreement with CSL Seqirus, which depends on a nine-month production cycle that leaves little room for equipment or raw material setbacks. It also comes as Australia records its highest Q fever case count since national monitoring began in 1991.

People who work with livestock, including dairy staff, may be unable to get vaccinated until supply resumes, so they should discuss their Q fever risk with a GP. The vaccine is available to people aged 15 and over.

The takeaway

Australians working with livestock should keep track of vaccine availability through their GP or health provider, as the shortage is expected to persist until late December 2026.

What happens next

Expedited vaccine batches are expected to become available in late December 2026, with the constrained supply situation expected to ease from later this year or early next year.

Further reading

For more on infectious disease outbreaks and vaccine supply, explore the COVID-19 section.

Live Poll

Do you think Australia's vaccine supply is reliable enough for rural communities?